- Investing Ideas
- /
- South Korean Pharmaceuticals & Biotech Leverage Leaders
South Korean Pharmaceuticals & Biotech Leverage Leaders
Results
14
14 companies
D&D Pharmatech
Market Cap: ₩3.9t
A clinical-stage biotech company, develops medicines in South Korea and the United States.
A347850
₩88,900.00
7D
-6.3%
1Y
497.6%
Hanmi Pharm
Market Cap: ₩5.6t
A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.
A128940
₩443,000.00
7D
-1.7%
1Y
56.5%
Peptron
Market Cap: ₩5.8t
Engages in the development of peptide-based medicines.
A087010
₩247,000.00
7D
7.6%
1Y
138.6%
ALTEOGEN
Market Cap: ₩24.4t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩457,000.00
7D
4.1%
1Y
43.5%
SK Biopharmaceuticals
Market Cap: ₩9.6t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩122,900.00
7D
-1.8%
1Y
12.5%
Samsung BiologicsLtd
Market Cap: ₩77.9t
Together with its subsidiaries engages in the manufacturing of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,683,000.00
7D
-0.5%
1Y
16.4%
Caregen
Market Cap: ₩3.6t
A biotechnology company, researches, develops, and commercializes biomimetic peptides worldwide.
A214370
₩73,800.00
7D
14.6%
1Y
132.4%
Aimed Bio
Market Cap: ₩3.5t
Develops therapeutic solutions for patients with brain diseases, including neuro-oncological and degenerative diseases.
A0009K0
₩54,700.00
7D
-15.7%
1Y
n/a
PharmaResearch
Market Cap: ₩4.5t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩434,000.00
7D
14.7%
1Y
66.6%
ABL Bio
Market Cap: ₩10.8t
A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.
A298380
₩195,500.00
7D
-1.8%
1Y
527.6%
Celltrion
Market Cap: ₩44.3t
A biopharmaceutical company, engages in the development, production, and sale of various therapeutic proteins for the treatment of oncology diseases.
A068270
₩202,500.00
7D
12.5%
1Y
16.4%
LigaChem Biosciences
Market Cap: ₩6.2t
A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
A141080
₩170,800.00
7D
-5.1%
1Y
44.6%
Yuhan
Market Cap: ₩8.4t
Manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods in South Korea and internationally.
A000100
₩112,800.00
7D
0.09%
1Y
-5.4%
Voronoi
Market Cap: ₩3.9t
Researches, develops, and discovers small molecule kinase inhibitors in South Korea.
A310210
₩215,000.00
7D
-5.9%
1Y
151.8%